PTSM: Pharmaceutical Technology Sourcing and Management, Jun 6, 2012 - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe
PTSM: Pharmaceutical Technology Sourcing and Management, Jun 6, 2012
Global Feature
Big Pharma's Mid-Year Review
By Patricia Van Arnum
The key activity of the pharmaceutical majors influencing drug development and manufacturing thus far in 2012.
Biotech
An Uneven Path for Biotech Financing
By Patricia Van Arnum
Venture-capital funding is up in 2012, but public financing remains sluggish in the biopharmaceutical industry.
Outsourcing
Channeling Steve Jobs
Service providers must focus on delivering a superior customer experience.
APIs
Seeking Chemocatalytic and Biocatalytic Solutions
By Patricia Van Arnum
Advances in palladium-catalyzed hydrogenation, visible-light photocatalysis, and chemocatalyisis for heterocycles are some recent developments.
Drug Delivery
Technical Insights: Targeted Drug Delivery
By Patricia Van Arnum
Needle-free jet injection systems, gold-coated nanoparticles, and elastic capsules with nanosized flakes advance targeted drug delivery.
CSR and Sustainability Forum
CSR and Sustainability in the News
A roundup of developments in corporate social responsibility and sustainability from the bio/pharmaceutical industry, its suppliers, and other public and private organizations.
Pharma Industry Responds to Global Health Initiatives
By Patricia Van Arnum
The pharmaceutical industry weighs in on WHO global health initiatives, including R&D for diseases of the developing world, a global vaccine action plan, neglected tropical diseases, and counterfeit medicines.

ADVERTISEMENT
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
How does your company apply quality-by-design (QbD) principles to manufacturing processes?
To all processes for both new and legacy products
To all process for new products only
To select process for new products only
To select processes for both new and legacy products
Do not use QbD
To all processes for both new and legacy products
21%
To all process for new products only
11%
To select process for new products only
25%
To select processes for both new and legacy products
21%
Do not use QbD
23%
View Results
Eric Langer Outsourcing Outlook Eric LangerOutsourcing's Modest Role as a Cost-Containment Strategy
Patricia Van Arnum Ingredients Insider Patricia Van ArnumIntellectual Property Battles in Solid-State Chemistry
Nathan Jessop Industry Insider Nathan Jessop Campaign Against Counterfeit Drugs Continues
Lynn Torbeck Statistical Solutions Lynn D. TorbeckCompositing Samples and the Risk to Product Quality
 More
FindPharma Custom Search
Featured Jobs

More Jobs
Click here